Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus Erythematosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04400240
What this trial is testing

Care Coordination Approaches to Learning Lupus Self-management

Who this might be right for
Systemic Lupus Erythematosus
Medical University of South Carolina 30
Testing effectiveness (Phase 2)Looking for participantsNCT05268289
What this trial is testing

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 240
Testing effectiveness (Phase 2)Looking for participantsNCT06347718
What this trial is testing

CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease

Who this might be right for
Systemic Lupus ErythematosusSystemic SclerosisDermatomyositis+1 more
Miltenyi Biomedicine GmbH 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT07266090
What this trial is testing

Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)

Who this might be right for
SLE - Systemic Lupus Erythematosus
Viatris Pharmaceuticals Co., Ltd. 15
Early research (Phase 1)Active Not RecruitingNCT06265220
What this trial is testing

AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus

Who this might be right for
Lupus Nephritis - WHO Class IIILupus Nephritis - WHO Class IVRefractory Systemic Lupus Erythematosus+1 more
Artiva Biotherapeutics, Inc. 51
Not applicableLooking for participantsNCT06232304
What this trial is testing

Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus of Childhood (Disorder)
Michigan State University 175
Large-scale testing (Phase 3)Not Yet RecruitingNCT07691970
What this trial is testing

Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

Who this might be right for
Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus
AstraZeneca 1,072
Not applicableEnded earlyNCT04141046
What this trial is testing

LUPUS Brain: tACS to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With SLE

Who this might be right for
Systemic Lupus ErythematosusDepression
University of North Carolina, Chapel Hill 4
Not applicableStudy completedNCT05176041
What this trial is testing

SLE Therapy Changes in Pregnancy and Relation to Pregnancy Outcome

Who this might be right for
Fetal Growth Retardation
University of Jordan 156
Testing effectiveness (Phase 2)UnknownNCT03054259
What this trial is testing

Rituximab Objective Outcome Measures Trial in SLE

Who this might be right for
Systemic Lupus Erythematosus Arthritis
University of Leeds 30
Early research (Phase 1)Looking for participantsNCT07236762
What this trial is testing

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis (LN)Sjogren's Syndrome+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Large-scale testing (Phase 3)UnknownNCT05631717
What this trial is testing

The Study of Comparing the Efficacy and Safety of Human Umbilical Cord MSCs and Low-dose IL-2 in the Treatment of LN

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Not applicableLooking for participantsNCT00198068
What this trial is testing

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

Who this might be right for
Systemic Lupus ErythematosusAntiphospholipid Syndrome
Hospital for Special Surgery, New York 700
Early research (Phase 1)Study completedNCT06144710
What this trial is testing

SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Hangzhou Sumgen Biotech Co., Ltd. 48
Not applicableNot Yet RecruitingNCT06287125
What this trial is testing

Renal Assessment for Early Detection of Renal Impairment in Systemic Sclerosis and Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Sclerosis and Systemic Lupus Erythematous
Assiut University 95
Not applicableStudy completedNCT01031797
What this trial is testing

QT Dispersion in Patients With Systemic Lupus Erythematosus (SLE)

Who this might be right for
SLE
Shiraz University of Medical Sciences 124
Early research (Phase 1)Study completedNCT01516450
What this trial is testing

Japanese phase1 Study of Belimumab (IV vs SC)

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 16
Not applicableStudy completedNCT00582465
What this trial is testing

Study to Evaluate the Natural History of Osteoporosis in Children and Adolescents With Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
University of California, San Francisco 243
Large-scale testing (Phase 3)Not Yet RecruitingNCT07814664
What this trial is testing

Ivarmacitinib Versus Glucocorticoids in Mild-to-Moderate Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erthematosus
Chinese SLE Treatment And Research Group 294
Post-approval studies (Phase 4)Active Not RecruitingNCT06677801
What this trial is testing

Immune Cell Subsets in SLE Patients Treated with Telitacicept

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Second Affiliated Hospital, Zhejiang University, School of Medicine 50
Next Page